GAID yields 0.72% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, GAID + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GAID + MRK for your $10,000?
GAID is an actively managed fund that invests in companies outside the US which consistently grow their dividends while maintaining company value. With a quality bias, GAID targets firms demonstrating strong and persistent returns on capital, sustainable dividend growth, and prudent levels of debt. The fund invests across market capitalizations, providing exposure to both developed and emerging markets, including Europe and Asia. The portfolio is typically equally weighted and holds around 30 to 35 positions. GAID offers more of an international exposure than the issuers global dividend builder ETF. The quality bar in the global ETF is so high, few international listed companies pass the screen selection.
Full GAID Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.